financetom
Business
financetom
/
Business
/
Citigroup, Carlyle to Explore Asset-Backed Financing Opportunities in Fintech Lending Segment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citigroup, Carlyle to Explore Asset-Backed Financing Opportunities in Fintech Lending Segment
Jun 12, 2025 9:11 AM

11:45 AM EDT, 06/12/2025 (MT Newswires) -- Citigroup ( C ) and Carlyle (CG) said Thursday they will collaborate on asset-backed financing opportunities in the fintech specialty lending segment.

The companies said they agreed on a framework to exchange market intelligence and explore financing opportunities, enhanced by the network of Citigroup's ( C ) Spread Products Investment in Technologies unit and Carlyle's credit and structuring know-how.

Price: 77.72, Change: -0.66, Percent Change: -0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla Board Neglecting Musk's 'Apparent Conflicts of Interest,' Sen Warren Says
Tesla Board Neglecting Musk's 'Apparent Conflicts of Interest,' Sen Warren Says
Aug 9, 2024
02:06 PM EDT, 08/09/2024 (MT Newswires) -- Tesla's (TSLA) board appears to be neglecting Elon Musk's apparent conflicts of interest involving his private companies and must act to ensure he is meeting his responsibilities as the chief executive officer of the publicly traded vehicle maker, Sen. Elizabeth Warren said Thursday in letter to Robyn Denholm, board chair Warren, a Massachusetts...
Chemed Insider Sold Shares Worth $2,781,897, According to a Recent SEC Filing
Chemed Insider Sold Shares Worth $2,781,897, According to a Recent SEC Filing
Aug 9, 2024
02:03 PM EDT, 08/09/2024 (MT Newswires) -- Thomas C Hutton, Director, Vice President, on August 06, 2024, sold 4,827 shares in Chemed ( CHE ) for $2,781,897. Following the Form 4 filing with the SEC, Hutton has control over a total of 32,765 shares of the company, with 32,765 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/19584/000095017024094535/xslF345X03/ownership.xml Price: 580.47, Change: -2.91, Percent...
Zentalis Pharmaceuticals Q2 Loss Narrows; Shares Fall
Zentalis Pharmaceuticals Q2 Loss Narrows; Shares Fall
Aug 9, 2024
02:17 PM EDT, 08/09/2024 (MT Newswires) -- Zentalis Pharmaceuticals ( ZNTL ) shares were down nearly 10% in recent trading on Friday after the company posted a wider-than-expected Q2 net loss. The company reported Q2 net loss of $1.24 per diluted share, narrowing from a loss of $1.85 a year earlier. Analysts polled by Capital IQ expected a loss of...
Nvr Insider Sold Shares Worth $1,046,596, According to a Recent SEC Filing
Nvr Insider Sold Shares Worth $1,046,596, According to a Recent SEC Filing
Aug 9, 2024
02:13 PM EDT, 08/09/2024 (MT Newswires) -- Melquiades R. Martinez, Director, on August 08, 2024, sold 125 shares in Nvr (NVR) for $1,046,596. Following the Form 4 filing with the SEC, Martinez has control over a total of 191 shares of the company, with 191 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/906163/000090616324000112/xslF345X03/wk-form4_1723226869.xml Price: 8480.00, Change: +54.59, Percent Change: +0.65 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved